{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:45:13Z","timestamp":1780433113251,"version":"3.54.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID\/NIH","doi-asserted-by":"publisher","award":["N01-AI-30050"],"award-info":[{"award-number":["N01-AI-30050"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DTRA-JSTO","award":["CB4080"],"award-info":[{"award-number":["CB4080"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.toxicon.2017.06.016","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T20:46:10Z","timestamp":1499546770000},"page":"36-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Small molecule metalloprotease inhibitor with in\u00a0vitro, ex\u00a0vivo and in\u00a0vivo efficacy against botulinum neurotoxin serotype A"],"prefix":"10.1016","volume":"137","author":[{"given":"Alan R.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-3681","authenticated-orcid":false,"given":"Michael","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Silvaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen N.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genessa M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.","family":"Fredenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Beak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad S.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Goodnough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Malizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Tepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul","family":"Tzipori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2017.06.016_bib1","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta. Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.toxicon.2017.06.016_bib2","series-title":"Molecular Aspects of Botulinum Neurotoxin, Current Topics in Neurotoxicity 4","first-page":"291","article-title":"Prevention and treatment of botulism","author":"Adler","year":"2014"},{"key":"10.1016\/j.toxicon.2017.06.016_bib3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0041-0101(00)00120-3","article-title":"Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle","volume":"39","author":"Adler","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.06.016_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0041-0101(95)00127-1","article-title":"Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin","volume":"34","author":"Adler","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.06.016_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0014-5793(98)00492-X","article-title":"Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity","volume":"429","author":"Adler","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2017.06.016_bib6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10571-011-9690-5","article-title":"Role of acetylcholinesterase on the structure and function of cholinergic synapses: insights gained from studies on knockout mice","volume":"31","author":"Adler","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/abio.2001.5028","article-title":"High throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity","volume":"291","author":"Anne","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pep.2004.05.009","article-title":"The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis and stability","volume":"37","author":"Baldwin","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.toxicon.2017.06.016_bib9","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/S0021-9258(18)61557-1","article-title":"Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis","volume":"262","author":"Bandyopadhyay","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/365160a0","article-title":"Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25","volume":"365","author":"Blasi","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2017.06.016_bib11","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1039\/b603099h","article-title":"Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model","author":"Boldt","year":"2006","journal-title":"Chem. Comm. (Camb.)"},{"key":"10.1016\/j.toxicon.2017.06.016_bib12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature03123","article-title":"Substrate recognition strategy for botulinum neurotoxin serotype A","volume":"432","author":"Breidenbach","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2017.06.016_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/acs.jmedchem.6b01393","article-title":"Newly designed quinolinol inhibitors mitigate the effects of botulinum neurotoxin A in enzymatic, cell- based and ex\u00a0vivo assays","volume":"60","author":"Bremer","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib14","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1074\/jbc.M608166200","article-title":"Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons","volume":"282","author":"Burnett","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/187152607780090667","article-title":"Strategies to design inhibitors of Clostridium botulinum neurotoxins","volume":"7","author":"Cai","year":"2007","journal-title":"Infect. Disord. Drug. Targets"},{"issue":"Web Server issue","key":"10.1016\/j.toxicon.2017.06.016_bib16","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2017.06.016_bib17","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1021\/bi00440a052","article-title":"Geometry of interaction of metal ions with sulfur-containing ligands in protein structures","volume":"28","author":"Chakrabarti","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2017.06.016_bib18","doi-asserted-by":"crossref","first-page":"9621","DOI":"10.1074\/jbc.M611211200","article-title":"Mechanism of substrate recognition by botulinum neurotoxin serotype A","volume":"282","author":"Chen","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib19","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"Antibody protection against botulinum neurotoxin intoxication in mice","volume":"77","author":"Cheng","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.toxicon.2017.06.016_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-013-8423-9","article-title":"Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction","volume":"48","author":"Colasante","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/WNF.0b013e31804b1a0d","article-title":"Iatrogenic botulism due to therapeutic botulinum toxin A injection in a pediatric patient","volume":"30","author":"Crowner","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/IAI.6.4.587-590.1972","article-title":"Role of protease in natural activation of Clostridium botulinum neurotoxin","volume":"6","author":"DasGupta","year":"1972","journal-title":"Infect. Immun."},{"issue":"Web Server issue","key":"10.1016\/j.toxicon.2017.06.016_bib23","doi-asserted-by":"crossref","first-page":"W615","DOI":"10.1093\/nar\/gkh398","article-title":"MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes","volume":"32","author":"Davis","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.toxicon.2017.06.016_bib24","first-page":"237","article-title":"Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters","volume":"84","author":"Dolly","year":"1990","journal-title":"J.\u00a0Physiol. Paris."},{"key":"10.1016\/j.toxicon.2017.06.016_bib25","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/1568026616666160413135630","article-title":"Searching for therpeutics against botulinum neurotoxins: a true challenge for drug discovery","volume":"16","author":"Duplantier","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/ml100074s","article-title":"Identification of a Natural product antagonist against the botulinum neurotoxin light chain protease","volume":"1","author":"Eubanks","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.toxicon.2017.06.016_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1107\/S0021889803006721","article-title":"POVScript+: a program for model and data visualization using persistence of vision ray-tracing","volume":"36","author":"Fenn","year":"2003","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.toxicon.2017.06.016_bib28","doi-asserted-by":"crossref","first-page":"18322","DOI":"10.1074\/jbc.271.31.18322","article-title":"Tyrosine phosphorylation modulates the activity of clostridial neurotoxins","volume":"271","author":"Ferrer-Montiel","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/10915810600961531","article-title":"Nonclinical vehicle use in studies by multiple routes in multiple species","volume":"25","author":"Gad","year":"2006","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bmcl.2016.11.019","article-title":"A\u00a0matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A","volume":"27","author":"Harrell","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.toxicon.2017.06.016_bib31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/cmdc.200800241","article-title":"Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophore","volume":"3","author":"Hermone","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.toxicon.2017.06.016_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/clinids\/23.2.337","article-title":"Experience with the use of an investigational F(ab\u2032)2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt","volume":"23","author":"Hibbs","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.toxicon.2017.06.016_bib33","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1345\/aph.1R646","article-title":"Foodborne botulism treated with heptavalent botulism antitoxin","volume":"47","author":"Hill","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.toxicon.2017.06.016_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.peptides.2015.07.003","article-title":"Botulinum neurotoxin: progress in negating its neurotoxicity; and in extending its therapeutic utility via molecular engineering","volume":"72","author":"Kostrzewa","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.toxicon.2017.06.016_bib35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1107\/S0021889891004399","article-title":"MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures","volume":"24","author":"Kraulis","year":"1991","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.toxicon.2017.06.016_bib36","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1016\/j.bmc.2015.10.024","article-title":"Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: insights from X-ray crystallography","volume":"23","author":"Kumaran","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/481455a","article-title":"Drug discovery: chemical beauty contest","volume":"481","author":"Leeson","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2017.06.016_bib38","doi-asserted-by":"crossref","first-page":"24223","DOI":"10.1074\/jbc.M113.451286","article-title":"The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site","volume":"288","author":"Mizanur","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib39","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/j.bmc.2009.03.013","article-title":"Botulinum neurotoxin serotype A inhibitors: small-molecule mercaptoacetamide analogs","volume":"17","author":"Moe","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxicon.2015.02.012","article-title":"Ex\u00a0vivo inhibition of Clostridium botulinum neurotoxin types B, C, E, and F by small molecular weight inhibitors","volume":"98","author":"Montgomery","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.06.016_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bmj.320.7228.161","article-title":"Uses of botulinum toxin injection in medicine today","volume":"320","author":"M\u00fcnchau","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.toxicon.2017.06.016_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1107\/S0907444906005270","article-title":"Optimal description of a protein structure in terms of multiple groups undergoing TLS motion","volume":"62","author":"Painter","year":"2006","journal-title":"Acta. Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.toxicon.2017.06.016_bib43","doi-asserted-by":"crossref","first-page":"e7730","DOI":"10.1371\/journal.pone.0007730","article-title":"Potent new small-molecule inhibitor of botulinum neurotoxin serotype A endopeptidase developed by synthesis-based computer-aided molecular design","volume":"4","author":"Pang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.toxicon.2017.06.016_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bmc.2005.08.018","article-title":"Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A","volume":"14","author":"Park","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib45","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1124\/jpet.106.104661","article-title":"An initial assessment of the systemic pharmacokinetics of botulinum toxin","volume":"318","author":"Ravichandran","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxicon.2017.06.016_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib47","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00141-09","article-title":"Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A","volume":"53","author":"Roxas-Duncan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxicon.2017.06.016_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ab.2011.01.002","article-title":"Detection of six serotypes of botulinum neurotoxin using fluorogenic reporters","volume":"411","author":"Ruge","year":"2011","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1994.tb26614.x","article-title":"Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus","volume":"710","author":"Schiavo","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.toxicon.2017.06.016_bib50","doi-asserted-by":"crossref","first-page":"23479","DOI":"10.1016\/S0021-9258(18)35863-0","article-title":"Botulinum neurotoxins are zinc proteins","volume":"267","author":"Schiavo","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib51","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1073\/pnas.0400584101","article-title":"Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: evidence for noncanonical zinc protease activity","volume":"101","author":"Segelke","year":"2004","journal-title":"Proc. Natl. Acad. Sci. (USA)"},{"key":"10.1016\/j.toxicon.2017.06.016_bib52","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1039\/C5CC00677E","article-title":"Toward the discovery of dual inhibitors for botulinum neurotoxin A: concomitant targeting of endocytosis and light chain protease activity","volume":"51","author":"Seki","year":"2015","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.toxicon.2017.06.016_bib53","first-page":"179","article-title":"Persistence of botulinum neurotoxin inactivation of nerve function","volume":"364","author":"Shoemaker","year":"2013","journal-title":"Curr. Top. Microrbiol. Immunol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10408410590912952","article-title":"Clostridium botulinum: a bug with beauty and weapon","volume":"31","author":"Shukla","year":"2005","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/ml300428s","article-title":"The C-terminus of botulinum A protease has profound and unanticipated kinetic consequences upon the catalytic cleft","volume":"4","author":"\u0160ilh\u00e1r","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.toxicon.2017.06.016_bib56","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.bmc.2012.12.001","article-title":"Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies","volume":"21","author":"\u0160ilh\u00e1r","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.toxicon.2017.06.016_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.chembiol.2007.03.014","article-title":"Structures of Clostridium botulinum neurotoxin serotype A light chain complexed with small-molecule inhibitors highlight active-site flexibility","volume":"14","author":"Silvaggi","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib58","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/bi8001067","article-title":"Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex","volume":"47","author":"Silvaggi","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2017.06.016_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","volume":"68","author":"Simpson","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.06.016_bib61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000112485","article-title":"A\u00a0procedure for purifying neuron-like cells in cultures from central nervous tissue with a defined medium","volume":"2","author":"Skaper","year":"1979","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.toxicon.2017.06.016_bib62","first-page":"302","article-title":"Diagnostic dilemma: intramuscular injection site injuries masquerading as pressure ulcers","volume":"15","author":"Treadwell","year":"2003","journal-title":"Wounds"},{"key":"10.1016\/j.toxicon.2017.06.016_bib63","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.toxicon.2010.07.003","article-title":"Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases","volume":"56","author":"Tremblay","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2017.06.016_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4315\/0362-028X-72.5.1005","article-title":"Egg yolk antibodies for detection and neutralization of Clostridium botulinum type A neurotoxin","volume":"72","author":"Trott","year":"2009","journal-title":"J.\u00a0Food. Prot."},{"key":"10.1016\/j.toxicon.2017.06.016_bib65","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1621076114","article-title":"Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication","author":"Tsai","year":"2017","journal-title":"Proc. Natl. Acad. Sci. (USA)"},{"key":"10.1016\/j.toxicon.2017.06.016_bib66","doi-asserted-by":"crossref","first-page":"42923","DOI":"10.1038\/srep42923","article-title":"Engineering botulinum neurotoxin C1 as a molecular vehicle for intra-neuronal drug delivery","volume":"7","author":"Vazquez-Cintron","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2017.06.016_bib67","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbagen.2013.03.031","article-title":"Quantification of thiols and disulfides","volume":"1840","author":"Winther","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2017.06.016_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1083\/jcb.201106158","article-title":"All three components of the neuronal SNARE complex contribute to secretory vesicle docking","volume":"198","author":"Wu","year":"2012","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.toxicon.2017.06.016_bib69","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1021\/bi500950x","article-title":"Probing BoNT\/A protease exosites: implications for inhibitor design and light chain longevity","volume":"53","author":"Xue","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.toxicon.2017.06.016_bib70","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/1087057109343206","article-title":"Neutralizing antibodies of botulinum neurotoxin serotype A screened from a fully synthetic human antibody phage display library","volume":"14","author":"Yu","year":"2009","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.toxicon.2017.06.016_bib71","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/pmic.201300242","article-title":"High throughput screening of disulfide-containing proteins in a complex mixture","volume":"13","author":"Zhao","year":"2013","journal-title":"Proteomics"},{"key":"10.1016\/j.toxicon.2017.06.016_bib72","doi-asserted-by":"crossref","first-page":"e11378","DOI":"10.1371\/journal.pone.0011378","article-title":"Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A","volume":"5","author":"Zuniga","year":"2010","journal-title":"PLoS One"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010117302052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010117302052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T13:44:50Z","timestamp":1617716690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010117302052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":72,"alternative-id":["S0041010117302052"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2017.06.016","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule metalloprotease inhibitor with in\u00a0vitro, ex\u00a0vivo and in\u00a0vivo efficacy against botulinum neurotoxin serotype A","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2017.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}